Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

crizotinib

  • You have access
    PrPC Regulates the Cancer Stem Cell Properties via Interaction With c-Met in Colorectal Cancer Cells
    JI HO LIM, GYEONGYUN GO and SANG HUN LEE
    Anticancer Research July 2021, 41 (7) 3459-3470; DOI: https://doi.org/10.21873/anticanres.15133
  • You have access
    ALK Inhibitors Do Not Increase Sensitivity to Radiation in EML4-ALK Non-small Cell Lung Cancer
    KATHRIN FLESCHUTZ, LISA WALTER, RUMO LEISTNER and LUCIE HEINZERLING
    Anticancer Research September 2020, 40 (9) 4937-4946; DOI: https://doi.org/10.21873/anticanres.14497
  • You have access
    Use of ALK Immunohistochemistry for Optimal Therapeutic Strategy of Pulmonary Large-cell Neuroendocrine Carcinoma and Identification of a Novel KIF5B–ALK Fusion Oncokinase
    NAOKI SHIMIZU, YUSAKU AKASHI, TOMOMI FUJII, HIROYUKI SHIONO, KATSUNARI YANE, TADASHI KITAHARA, YOSHIO OHTA, KENNICHI KAKUDO and TOMOKO WAKASA
    Anticancer Research January 2019, 39 (1) 413-420; DOI: https://doi.org/10.21873/anticanres.13127
  • You have access
    Directed Therapies in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer
    RALPH L. MILLETT, JACOB M. ELKON and IMAD A. TABBARA
    Anticancer Research September 2018, 38 (9) 4969-4975; DOI: https://doi.org/10.21873/anticanres.12815
  • You have access
    MET Expressed in Glioma Stem Cells Is a Potent Therapeutic Target for Glioblastoma Multiforme
    TAKAYUKI TASAKI, MITSUGU FUJITA, TAKESHI OKUDA, AZUSA YONESHIGE, SUSUMU NAKATA, KIMIHIRO YAMASHITA, HIROMASA YOSHIOKA, SHUICHI IZUMOTO and AMAMI KATO
    Anticancer Research July 2016, 36 (7) 3571-3577;
  • You have access
    Crizotinib Fails to Enhance the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Xenografts
    ANDREW M. BASCHNAGEL, SANDRA GALOFORO, BRYAN J. THIBODEAU, SAMREEN AHMED, SONALI NIRMAL, JAN AKERVALL and GEORGE D. WILSON
    Anticancer Research November 2015, 35 (11) 5973-5982;
  • You have access
    Liposomes Ameliorate Crizotinib- and Nilotinib-induced Inhibition of the Cardiac IKr Channel and QTc Prolongation
    GEORGE M. SHOPP, LAWRENCE HELSON, ANNIE BOUCHARD, DANY SALVAIL and MUHAMMAD MAJEED
    Anticancer Research September 2014, 34 (9) 4733-4740;
  • You have access
    Status of Anaplastic Lymphoma Kinase (ALK) in Malignant Mesothelioma
    SERENA VARESANO, CLAUDIO LEO, SIMONA BOCCARDO, SANDRA SALVI, MAURO TRUINI, PAOLA FERRO, FRANCO FEDELI, PIER ALDO CANESSA, PAOLO DESSANTI, MARIA PIA PISTILLO and SILVIO RONCELLA
    Anticancer Research May 2014, 34 (5) 2589-2592;
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire